JAMA Pediatrics Editors' Summary

Long-term Survival and Value of CAR T-Cell Therapy for Pediatric Patients with Relapsed or Refractory Leukemia; Assessment of Exposure to High-Performing Schools and Risk of Adolescent Substance Use

12.03.2018 - By JAMA NetworkPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

JAMA Pediatrics Editors' Summary by Dimitri Christakis, MD, MPH, Editor in Chief, and Frederick Rivara, MD, MPH, Editor of JAMA Network Open, for the December 3, 2018 issue

More episodes from JAMA Pediatrics Editors' Summary